Literature DB >> 22098810

Drug treatment of obesity.

George A Bray1, Donna H Ryan.   

Abstract

Both diet and medications are useful in the treatment of the obese patient. Weight loss of about 10% below baseline can be achieved with both, and there is no evidence that the composition of the diet, by itself, has any influence on weight loss. Presently only 1 drug is approved for long-term treatment of overweight patients, and its effectiveness is limited to palliation of the chronic disease of obesity. Combinations of medications and antidiabetic drugs that produce weight loss are being evaluated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22098810     DOI: 10.1016/j.psc.2011.08.013

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  7 in total

Review 1.  New pharmacological approaches for obesity management.

Authors:  Christian F Rueda-Clausen; Raj S Padwal; Arya M Sharma
Journal:  Nat Rev Endocrinol       Date:  2013-06-11       Impact factor: 43.330

2.  Effects of topiramate, bupropion and naltrexone isolated or combined on subcutaneous adipose tissue in obese rats.

Authors:  Monica Alhadas Scudeler; Stephania Morreale; Lorena Doretto-Silva; Giuliana Petri; José Francisco Ramos Dos Santos; Cristina Nassis; Olga Maria de Toledo Correa; Juliana Mora Veridiano
Journal:  Einstein (Sao Paulo)       Date:  2022-05-30

Review 3.  Pharmacokinetic-Pharmacodynamic (PKPD) Analysis with Drug Discrimination.

Authors:  S Stevens Negus; Matthew L Banks
Journal:  Curr Top Behav Neurosci       Date:  2018

Review 4.  Early impact of bariatric surgery on type II diabetes, hypertension, and hyperlipidemia: a systematic review, meta-analysis and meta-regression on 6,587 patients.

Authors:  Cristian Ricci; Maddalena Gaeta; Emanuele Rausa; Yuri Macchitella; Luigi Bonavina
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

5.  Leptin action through hypothalamic nitric oxide synthase-1-expressing neurons controls energy balance.

Authors:  Rebecca L Leshan; Megan Greenwald-Yarnell; Christa M Patterson; Ian E Gonzalez; Martin G Myers
Journal:  Nat Med       Date:  2012-05       Impact factor: 53.440

6.  Significance of Kampo, Japanese traditional medicine, in the treatment of obesity: basic and clinical evidence.

Authors:  Jun-Ichi Yamakawa; Junji Moriya; Kenji Takeuchi; Mio Nakatou; Yoshiharu Motoo; Junji Kobayashi
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-15       Impact factor: 2.629

Review 7.  Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date.

Authors:  Assumpta Caixàs; Lara Albert; Ismael Capel; Mercedes Rigla
Journal:  Drug Des Devel Ther       Date:  2014-09-18       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.